Click Here for 5% Off Your First Aladdin Purchase!
Call +1 (833) 552-7181 or Contact us Earn $25 in coupons on your first order with Aladdin!
Toggle Nav
My Cart
Search
Advanced Search
Menu
Sign In
྾
main product photo

Polyethylene Glycol Monododecyl Ether - for membrane research, high purity , CAS No.9002-92-0

  • for membrane research
Item Number
T434384
Grouped product items
SKUSizeAvailabilityPrice Qty
T434384-5g
5g
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$50.90
T434384-25g
25g
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$149.90
T434384-100g
100g
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$459.90
Add to Wish List Compare
Bulk Order  SDS  DATASHEET

Basic Description

SynonymsPolidocanol；Polyethylene glycol 400 dodecyl ether；Macrogol lauryl ether；Lauromacrogol； Polyethylene glycol dodecyl ether； Hydroxypolyethoxydodecane
Specifications & Purityfor membrane research
Storage TempStore at 2-8°C,Argon charged
Shipped InWet ice
Product Description

Molecular weight: Approximately 600 D（ n=approximately 9） 

Nonionic detergent for use in diagnostic reagents. 

Use Polidocanol in diagnostic reagents to enhance solubility, minimize interferences and reduce carryover effects.

Application

Thesit has been used in the reaction buffer to reduce the background sedimentation. Suggested substitute for Lubrol in the preparation of G protein from bovine brain.

Names and Identifiers

PubChem CID 254787116

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

5 results found

Lot NumberCertificate TypeDateItem
L2315369Certificate of AnalysisDec 09, 2023 T434384
L2315370Certificate of AnalysisDec 09, 2023 T434384
L2315371Certificate of AnalysisDec 09, 2023 T434384
L2315372Certificate of AnalysisDec 09, 2023 T434384
L2315373Certificate of AnalysisDec 09, 2023 T434384

Chemical and Physical Properties

SensitivityMoisture sensitive
Flash Point(°C)113°C
Boil Point(°C)100℃
Melt Point(°C)37 °C

Safety and Hazards(GHS)

Pictogram(s) GHS09,   GHS07
Signal Warning
Hazard Statements

H319:Causes serious eye irritation

H302:Harmful if swallowed

H410:Very toxic to aquatic life with long lasting effects

Precautionary Statements

P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing.

P273:Avoid release to the environment.

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P264:Wash hands [and …] thoroughly after handling.

P270:Do not eat, drink or smoke when using this product.

P337+P313:IF eye irritation persists: Get medical advice/attention.

P391:Collect spillage.

P330:Rinse mouth.

P301+P312:IF SWALLOWED: call a POISON CENTER/doctor/... IF you feel unwell.

Class 9

Related Documents

 SDS

 Specification Sheet

Alternative Products

  1. Brij™ L23
    Brij™ L23

    Starting at $12.90

  2. Brij® L23 - suitable for Stein-Moore chromatography, used for , CAS No. 9002-92-0, by Aladdin Scientific
    Brij® L23

    Starting at $156.90

  3. Brij® L4
    Brij® L4

    Starting at $9.90

  4. Brij®L23 concentrate
    Brij®L23 concentrate

    Starting at $89.90

  5. Decaethylene glycol mono­dodecyl ether
    Decaethylene glycol mono­dodecyl ether

    Starting at $217.90

  6. Brij™ L23
    Brij™ L23

    Starting at $24.90

  7. Brij® L4
    Brij® L4

    Starting at $41.90

  8. Brij® L23 solution - 30 % (w/v) in H2O, used for , CAS No. 9002-92-0, by Aladdin Scientific
    Brij® L23 solution

    Starting at $200.90

References

1. E Weisshaar,G Heyer,C Forster,O P Hornstein,H O Handwerker.  (1996-05-01)  [Antipruritic effect of antihistaminic and local anesthetic topical agents after iontophoretic histamine stimulation]..  Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,  47  ((5)): (355-360).  [PMID:8707580]
2. Ryuichi Ueoka,Yuji Komizu,Yoko Matsumoto,Yu Zhong,Ritsuko Tanaka,Naoki Yamamoto.  (2008-08-02)  Selective inhibitory effects of hybrid liposomes on the growth of HIV type 1-infected cells in vitro..  Bioorganic & medicinal chemistry letters,  18  ((16)): (4578-4580).  [PMID:18672367]
3. Hideaki Ichihara,Motoki Hino,Taku Makizono,Masayo Umebayashi,Yoko Matsumoto,Ryuichi Ueoka.  (2010-12-03)  Inhibitory effects of hybrid liposomes on the growth of synoviocyte causing rheumatoid arthritis..  Bioorganic & medicinal chemistry letters,  21  ((1)): (207-210).  [PMID:21123065]
4. Jacomina W van den Esschert,Krijn P van Lienden,Lindy K Alles,Albert C van Wijk,Michal Heger,Joris J Roelofs,Thomas M van Gulik.  (2012-01-14)  Liver regeneration after portal vein embolization using absorbable and permanent embolization materials in a rabbit model..  Annals of surgery,  255  ((2)): (311-318).  [PMID:22241291]
5. Albert-Adrien Ramelet.  (2012-01-25)  Sclerotherapy in tumescent anesthesia of reticular veins and telangiectasias..  Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.],  38  ((5)): (748-751).  [PMID:22268802]
6. Sabrina G Fabi,Mitchel P Goldman.  (2012-01-25)  Hand rejuvenation: a review and our experience..  Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.],  38  ((7 Pt 2)): (1112-1127).  [PMID:22268976]
7. S Rathbun,A Norris,J Stoner.  (2012-02-22)  Efficacy and safety of endovenous foam sclerotherapy: meta-analysis for treatment of venous disorders..  Phlebology,  27  ((3)): (105-117).  [PMID:22349606]
8. Adriana Smarandache.  (2012-03-16)  Laser beams interaction with polidocanol foam: molecular background..  Photomedicine and laser surgery,  30  ((5)): (262-267).  [PMID:22417110]
9. Darío Morais,Teresa Millás,Roberto Zarrabeitia,Luisa M Botella,Ana Almaraz.  (2012-04-04)  Local sclerotherapy with polydocanol (Aethoxysklerol®) for the treatment of Epistaxis in Rendu-Osler-Weber or Hereditary Hemorrhagic Telangiectasia (HHT): 15 years of experience..  Rhinology,  50  ((1)): (80-86).  [PMID:22469609]
10. B McAree,A Ikponmwosa,K Brockbank,C Abbott,S Homer-Vanniasinkam,M J Gough.  (2012-04-18)  Comparative stability of sodium tetradecyl sulphate (STD) and polidocanol foam: impact on vein damage in an in-vitro model..  European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery,  43  ((6)): (721-725).  [PMID:22507925]
11. Kurosh Parsi,David E Connor,Anne Pilotelle,Joyce Low,David D F Ma,Joann.  (2012-04-26)  Low concentration detergent sclerosants induce platelet activation but inhibit aggregation due to suppression of GPIIb/IIIa activation in vitro..  Thrombosis research,  130  ((3)): (472-478).  [PMID:22531012]
12. D Sato,M Kurita,M Ozaki,N Kaji,A Takushima,K Harii.  (2012-05-02)  Extravascular injection of sclerotic agents does not affect vessels in the rat: experimental implications for percutaneous sclerotherapy of arteriovenous malformations..  European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery,  44  ((1)): (73-76).  [PMID:22546640]
13. Takashi Yamaki,Hisato Konoeda,Daisuke Fujisawa,Kota Ogino,Atsuyoshi Osada,Atsumori Hamahata,Motohiro Nozaki,Hiroyuki Sakurai.  (2012-05-23)  Changes in calf muscle deoxygenation after foam sclerotherapy in patients with superficial venous insufficiency..  Journal of vascular surgery,  56  ((6)): (1649-1655).  [PMID:22608181]
14. Jennifer D Peterson,Mitchel P Goldman,Robert A Weiss,David M Duffy,Sabrina G Fabi,Margaret A Weiss,Isabella Guiha.  (2012-05-25)  Treatment of reticular and telangiectatic leg veins: double-blind, prospective comparative trial of polidocanol and hypertonic saline..  Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.],  38  ((8)): (1322-1330).  [PMID:22620717]
15. N Shadid,R Ceulen,P Nelemans,C Dirksen,J Veraart,G W Schurink,P van Neer,J vd Kley,E de Haan,A Sommer.  (2012-05-26)  Randomized clinical trial of ultrasound-guided foam sclerotherapy versus surgery for the incompetent great saphenous vein..  The British journal of surgery,  99  ((8)): (1062-1070).  [PMID:22627969]
16. Masahide Fujiki,Masakazu Kurita,Mine Ozaki,Hayato Kawakami,Nobuyuki Kaji,Akihiko Takushima,Kiyonori Harii.  (2012-06-13)  Detrimental influences of intraluminally-administered sclerotic agents on surrounding tissues and peripheral nerves: an experimental study..  Journal of plastic surgery and hand surgery,  46  ((3-4)): (145-151).  [PMID:22686430]
17. S Reich-Schupke,A Leiste,R Moritz,P Altmeyer,M Stücker.  (2012-07-25)  Sclerotherapy in an undetected pregnancy - a catastrophe?.  VASA. Zeitschrift fur Gefasskrankheiten,  41  ((4)): (243-247).  [PMID:22825857]
18. .  (2012-08-10)  Management of chronic Achilles tendinopathy..  Drug and therapeutics bulletin,  50  ((8)): (93-96).  [PMID:22875366]
19. Amish Patel,Aaron M Fischman,Wael E Saad.  (2012-09-22)  Balloon-occluded retrograde transvenous obliteration of gastric varices..  AJR. American journal of roentgenology,  199  ((4)): (721-729).  [PMID:22997361]
20. Vikas Kumar Sarna,Njaal Stray.  (2012-10-06)  A young woman with upper gastrointestinal bleeding..  Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,  132  ((18)): (2070-2072).  [PMID:23038199]
21. A Erkin,K Kosemehmetoglu,M S Diler,C Koksal.  (2012-11-06)  Evaluation of the minimum effective concentration of foam sclerosant in an ex-vivo study..  European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery,  44  ((6)): (593-597).  [PMID:23122185]
22. Ramon R J P van Eekeren,Doeke Boersma,Vincent Konijn,Jean Paul P M de Vries,Michel M J P Reijnen.  (2012-11-13)  Postoperative pain and early quality of life after radiofrequency ablation and mechanochemical endovenous ablation of incompetent great saphenous veins..  Journal of vascular surgery,  57  ((2)): (445-450).  [PMID:23141679]
23. Manuel Moretó,Enrique Ojembarrena,Angel Barturen,Ignacio Casado.  (2012-11-28)  Treatment of achalasia by injection of sclerosant substances: a long-term report..  Digestive diseases and sciences,  58  ((3)): (788-796).  [PMID:23179151]
24. Stefanie Reich-Schupke,Martin Doerler,Peter Altmeyer,Markus Stücker.  (2013-02-07)  Foam sclerotherapy with enoxaparin prophylaxis in high-risk patients with postthrombotic syndrome..  VASA. Zeitschrift fur Gefasskrankheiten,  42  ((1)): (50-55).  [PMID:23385226]
25. F Ferrara,G Ferrara.  (2013-03-16)  Treating telangiectasias: my method..  Minerva cardioangiologica,  61  ((2)): (221-227).  [PMID:23492605]
26. G C Valenzuela,K Wong,D E Connor,M Behnia,K Parsi.  (2013-09-28)  Foam sclerosants are more stable at lower temperatures..  European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery,  46  ((5)): (593-599).  [PMID:24070851]
27. Otte Brosjö,Pierre Pechon,Asle Hesla,Panagiotis Tsagozis,Henrik Bauer.  (2013-11-01)  Sclerotherapy with polidocanol for treatment of aneurysmal bone cysts..  Acta orthopaedica,  84  ((5)): (502-505).  [PMID:24171682]
28. L Lund,A Kloster,T Cao.  (2013-11-23)  The long-term efficacy of hydrocele treatment with aspiration and sclerotherapy with polidocanol compared to placebo: a prospective, double-blind, randomized study..  The Journal of urology,  191  ((5)): (1347-1350).  [PMID:24262498]
29. Misaki M Kiguchi,Eric S Hager,Daniel G Winger,Stanley A Hirsch,Rabih A Chaer,Ellen D Dillavou.  (2014-01-11)  Factors that influence perforator thrombosis and predict healing with perforator sclerotherapy for venous ulceration without axial reflux..  Journal of vascular surgery,  59  ((5)): (1368-1376).  [PMID:24406088]
30. .  (2014-01-11)  Discussion..  Journal of vascular surgery,  59  ((5)): (1375-1376).  [PMID:24406091]
31. Amir M Ghaznavi,Mio Nakamura,Donna Tepper.  (2014-12-19)  An analysis of 72% chromated glycerin used for sclerotherapy: sterility, potency, and cost after extended shelf life..  Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.],  41  ((1)): (121-125).  [PMID:25521102]
32. Chuanyu Yang,Charles A Powell,Yongping Duan,Robert Shatters,Muqing Zhang.  (2015-07-25)  Antimicrobial Nanoemulsion Formulation with Improved Penetration of Foliar Spray through Citrus Leaf Cuticles to Control Citrus Huanglongbing..  PloS one,  10  ((7)): (e0133826-e0133826).  [PMID:26207823]
33. Bo Li,Shin-Ichi Makino,Emily T Beebe,Daisuke Urano,David J Aceti,Tina M Misenheimer,Jonathan Peters,Brian G Fox,Alan M Jones.  (2016-05-11)  Cell-free translation and purification of Arabidopsis thaliana regulator of G signaling 1 protein..  Protein expression and purification,  126  (33-41).  [PMID:27164033]
34. J Dingus,M D Wilcox,R Kohnken,J D Hildebrandt.  (1994-01-01)  Synthesis and use of biotinylated beta gamma complexes prepared from bovine brain G proteins..  Methods in enzymology,  237  (457-471).  [PMID:7935020]
35. Alessandro Frullini,Maria Chiara Barsotti,Tatiana Santoni,Emiliano Duranti,Silvia Burchielli,Rossella Di Stefano.  (2012-05-01)  Significant endothelin release in patients treated with foam sclerotherapy..  Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.],  38  ((5)): (741-747).  [PMID:22540861]

Solution Calculators

Privacy Policy Website Terms of Use Return policy Terms and Conditions of Sale Cookie Policy Sales Policy
Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.
Copyright © 2023-present Aladdin Scientific Corp . All rights reserved.